SCHEMBL24022985

SCHEMBL24022985

CC(C)Oc1ccc2c(c1)CCn1cc(C(=O)O)c(=O)cc1-2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
KMT2A Q03164 1/20 0.37
EZH2 Q15910 1/20 0.35
ACACB O00763 1/20 0.35
KDM4C Q9H3R0 1/20 0.34
PTGDR2 Q9Y5Y4 1/20 0.34
KDM4E B2RXH2 2/20 0.34
LMNA P02545 2/20 0.34
NPC1 O15118 1/20 0.34
MAPT P10636 1/20 0.34
PKM P14618 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
POLB P06746 1/20 0.34
RECQL P46063 1/20 0.34
ITGB3 P05106 2/20 0.34
ITGA2B P08514 2/20 0.34
GLA P06280 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23060734 0.88 KDM4E (0.44) ALDH1A1KMT2AKDM4ENPC1MAPT
SCHEMBL16973549 0.82 ITGB3 (0.44) ITGB3ITGA2B
SCHEMBL29374541 0.79 SMN1; SMN2 (0.40) ALDH1A1KDM4ERAB9ASMN1; SMN2POLB
SCHEMBL29376705 0.78 KDM4E (0.56) ALDH1A1KDM4ELMNANPC1MAPT
SCHEMBL16973719 0.75 HTT (0.41) KMT2AITGB3ITGA2B
SCHEMBL17266002 0.74 ACHE (0.40) KMT2AKDM4E
SCHEMBL16929831 0.74 TSHR (0.40) LMNAMAPTTSHR
SCHEMBL21824326 0.71 NPC1 (0.47) ALDH1A1KMT2AKDM4ENPC1MAPT
SCHEMBL21473723 0.70 BCHE (0.34)
SCHEMBL22693539 0.70 AOC3 (0.53) KMT2AEZH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3732177-B1 DIHYDROPYRIMIDINYLTHIAZOLE FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION HOFFMANN LA ROCHE (CH) 2021-11-17 EP disclosed